Alector
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Alector and other ETFs, options, and stocks.About ALEC
Alector, Inc. operates as a clinical-stage biopharmaceutical company, which engages in pioneering of immuno-neurology. It develops portfolio of innate immune system programs, designed to functionally repair genetic mutations and enable the rejuvenated immune cells to counteract emerging brain pathologies.
CEOArnon Rosenthal
CEOArnon Rosenthal
Employees238
Employees238
HeadquartersSouth San Francisco, California
HeadquartersSouth San Francisco, California
Founded2013
Founded2013
Employees238
Employees238
ALEC Key Statistics
Market cap212.30M
Market cap212.30M
Price-Earnings ratio-1.82
Price-Earnings ratio-1.82
Dividend yield—
Dividend yield—
Average volume900.92K
Average volume900.92K
High today$1.98
High today$1.98
Low today$1.89
Low today$1.89
Open price$1.97
Open price$1.97
Volume927.82K
Volume927.82K
52 Week high$3.40
52 Week high$3.40
52 Week low$0.87
52 Week low$0.87
Stock Snapshot
As of today, Alector(ALEC) shares are valued at $1.95. The company's market cap stands at 212.3M, with a P/E ratio of -1.82.
On 2026-02-10, Alector(ALEC) stock moved within a range of $1.89 to $1.98. With shares now at $1.95, the stock is trading +3.2% above its intraday low and -1.5% below the session's peak.
Trading volume for Alector(ALEC) stock has reached 927.82K, versus its average volume of 900.92K.
Over the past 52 weeks, Alector(ALEC) stock has traded between a high of $3.40 and a low of $0.87.
Over the past 52 weeks, Alector(ALEC) stock has traded between a high of $3.40 and a low of $0.87.
Analyst ratings
63%
of 8 ratingsBuy
12.5%
Hold
62.5%
Sell
25%
People also own
Based on the portfolios of people who own ALEC. This list is generated using Robinhood data, and it’s not a recommendation.